Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Revenue 2017–2025
Sunshine Biopharma Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sunshine Biopharma Inc. revenue for the quarter ending March 31, 2026 was 8.1 M, a 9.13% decrease year-over-year.
- Sunshine Biopharma Inc. revenue for the twelve months ending March 31, 2026 was 35.8 M, a 14.66% increase year-over-year.
- Sunshine Biopharma Inc. annual revenue for 2025 was 36.3 M, a 4.11% increase from 2024.
- Sunshine Biopharma Inc. annual revenue for 2024 was 34.9 M, a 44.75% increase from 2023.
- Sunshine Biopharma Inc. annual revenue for 2023 was 24.1 M, a 454.42% increase from 2022.
- Sunshine Biopharma Inc. annual revenue for 2022 was 4.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. Earnings — FAQ
Sunshine Biopharma Inc. (SBFM) earnings over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SBFM's earnings history?
The chart and table above show Sunshine Biopharma Inc.'s earnings by year and by quarter, including the growth rate.